Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
about
A pilot study on screening blood donors with individual-donation nucleic acid testing in China.Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern IndiaPrevalence of occult hepatitis B virus infectionManagement of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.Occult hepatitis B virus infection and blood transfusionSensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samplesCriteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group.Reducing the risk of hepatitis B virus transfusion-transmitted infectionMutations associated with occult hepatitis B in HIV-positive South AfricansNeed for nucleic Acid testing in countries with high prevalence of transfusion-transmitted infections.Occult Hepatitis B (OBH) in Clinical Settings.Bayesian regression for group testing data.New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.Nucleic acid testing: Is it the only answer for safe Blood in India?PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantationHepatitis B virus infection and transfusion medicine: science and the occult.Hepatitis B virus traceback and lookback: factors to consider.Hierarchical group testing for multiple infections.First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen.Assessment of semi-automated nucleic acid testing programme in a Regional Blood Transfusion Centre.Prevalence of occult hepatitis B infection in patients visiting tertiary care hospitalOccult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc TestingThe yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.A study on optimization of plasma pool size for viral infectious markers in Indian blood donors using nucleic acid amplification testing.Hepatitis B core antibody-positive donors in cardiac transplantation: a single-center experience.Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors.An overview of occult hepatitis B virus infection.Procleix Ultrio transcription-mediated amplification vs. serological blood screening in south-western Greece.A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.Preanalytical stability of HIV-1 and HCV RNA: impact of storage and plasma separation from cells on blood donation testing by NAT.Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples.Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase.Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.False-positive nucleic acid test results for human immunodeficiency virus RNA and hepatitis C virus RNA: an underappreciated problem.A new method of concentrating hepatitis B virus (HBV) DNA and HBV surface antigen: an application of the method to the detection of occult HBV infection.Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with men.Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia.
P2860
Q33690837-962CD55D-4D4F-42D5-AC8C-6631F9633E69Q33773235-466361F1-942E-4AE5-B795-09DD40FB5F4EQ34757367-CD8EAD9F-879D-42B5-9A3A-B0EF0A2AF676Q35095916-28597262-A430-4995-98D6-493809DD6D11Q35164580-444F9A1E-788E-4560-82B4-0D1096EF31C0Q35237335-A3D8D03A-8C10-448C-B438-2724092939B5Q35265179-DF240DCF-B529-4C5B-93C4-57080D7A2CDFQ35434455-C73A5281-AEFE-481A-9BC8-BE632273ECB0Q35683881-BFDC4D0D-C627-4D0B-AAF8-19E878DD34B0Q36035578-137E4EA9-DB8B-4238-AE30-14CDE1818CDDQ36248372-D0D3E6B7-D6DB-4E37-AB65-B318853690BBQ36328982-38D1068D-827D-4EAA-94B9-3B453954A7A9Q36345652-1230A793-9599-40BB-8F9C-07F695B8EA6AQ36466447-9FEDB58F-5C70-431C-A80A-AB92389339ECQ36662780-86AA6636-FF16-4403-9175-619BA0FE5D53Q36909187-07857E44-9636-4875-AA7C-E194586958FEQ37153782-AC43DA99-0F66-4B6D-A03C-A32D81D658F8Q37367451-86443F23-7023-4D9A-B6DB-D161ED99EE1EQ37716317-C22DE5CD-4C79-44F1-8899-5C4FD6860AEAQ38421534-265AE093-4B50-4930-80C4-85503EC1B19BQ39788643-3D48A36D-D71F-42F9-93F2-476A973EFE6BQ40402813-677EDA24-C047-45F5-B2F9-DD248E863532Q40647527-2C56EBDE-C71B-49FE-ABE8-DBFEF4EAEC5CQ41111337-83CEFB76-ED2A-4474-B9A0-FFDC38647008Q41606333-0185100C-7317-43C5-B9C3-D1E29753CCA1Q42143374-BC53FD59-5074-468F-9853-3C657ED6FEA2Q42198117-A9F29B6D-F620-409B-852A-06A2E9A6C544Q42224176-C51FF592-291A-42E6-A384-6B6CE624AC20Q42722415-81172F18-6D3C-4240-BFAC-F1B8D30650A0Q42977683-D245C6D6-D74F-4094-8A42-50319F7BE9FFQ42977855-6667A0ED-2448-47ED-A48D-D4596CAC2686Q43001633-9035C7C3-F50F-476F-BC8F-47269D0EF59DQ43588340-10376CBD-46D5-4873-9D7A-78F7BB4038CCQ44012614-C14245B3-BC64-4C11-B547-C40017B8C54CQ45183486-2B401C24-9EF2-496B-9D2E-3EFDD4142546Q45359766-28C13DF2-FBE7-48B8-82D4-30788321EFFFQ45369944-C640F6A5-D2FC-4C6D-82B9-E29E5F61D002Q45387593-AA628E7F-BD48-495A-B4B6-0CCFD6609C3EQ46589701-E8027602-FA20-4480-9E0A-EE18EEC39B1CQ47552167-55B2D74C-BB6E-4584-A3ED-BC7C84850130
P2860
Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hepatitis B virus (HBV) DNA sc ...... he COBAS AmpliScreen HBV test.
@en
type
label
Hepatitis B virus (HBV) DNA sc ...... he COBAS AmpliScreen HBV test.
@en
prefLabel
Hepatitis B virus (HBV) DNA sc ...... he COBAS AmpliScreen HBV test.
@en
P2093
P1433
P1476
Hepatitis B virus (HBV) DNA sc ...... he COBAS AmpliScreen HBV test.
@en
P2093
Chiacchierini RP
Holland PV
Kleinman SH
Pietrelli LA
Tegtmeier GG
P304
P356
10.1111/J.1537-2995.2005.00198.X
P577
2005-08-01T00:00:00Z